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Detection Of Human Papilloma Virus (Type 16 And
18) In Cytological Samples In Patients With Lung
Cancer. An Evaluation By Chromogenic In Situ Hybri-
dization Technique
Nada Al-Shabbani
Al Karama Teaching Hospital, Baghdad, Iraq
Background: Lung cancer is a common neoplasm. Some studies
suggested that HPV may play an etiologic role in bronchial
carcinogenesis and possibility of a latent HPV infection as a
cocarcinogen cannot be excluded. HPV (high risk types) 16 &18
may affect the cell cycle and inhibit apoptosis, allowing uncon-
trolled cell division.
Aims of study: 1. To use bronchial wash as a non invasive
procedure to determine the presence of DNA of high risk types
(16 &18 )of HPV in patients with lung cancer using in situ
hybridization technique. 2. To Find the association of the score
or intensity of viral in situ hybridization signals with histopatho-
logical types.
Patients, Materials and methods: A prospective study, whereby
bronchial wash of 50 patients diagnosed cytologicaly as having
lung cancer together with samples from 30 patient having chronic
illness as control.
Results: The most affected age group was 66–70 years (28% of the
cases). Males were affected more frequently than females (64.0%).
Regarding HPV16 & 18 and histological types of lung cancer the
commonest effected type was squamouse cell carcinoma showed
positive signals in 32% and 28% for HPV16&HPV18 respectively.
Percentage score and intensity score: Lung cancer samples showed
low intensity signals for human papilloma virus16 in 63.6% of
samples and 44.5% for human papilloma virus 18.
Conclusions: Human papilloma virus 16 and 18 was detected in
cytological bronchial samples of patients with lung cancer in
relatively high percentage
http://dx.doi.org/10.1016/j.redox.2015.09.019
Stabilization Of Apoptotic Cells: Generation Of Zom-
bie Cells
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David Cotán, Marina Villanueva Paz, Ana Delgado Pavón,
Elisabet Alcocer Gómez, Antonio Rodríguez Moreno
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Apoptosis is characterized by degradation of cell components
but plasma membrane remains intact. Apoptotic microtubule
network (AMN) is organized during apoptosis forming a cortical
structure beneath plasma membrane that maintains plasma
membrane integrity. Apoptotic cells are also characterized by high
reactive oxygen species (ROS) production that can be potentially
harmful for the cell. The aim of this study was to develop a method
that allows stabilizing apoptotic cells for diagnostic and therapeutic
applications. We were able by using a cocktail composed of taxol (a
microtubule stabilizer), Zn2+ (a caspase inhibitor) and coenzyme Q10
(a lipid antioxidant) to stabilize H460 apoptotic cells in cell cultures
for at least 72 hours preventing secondary necrosis. Stabilized
apoptotic cells maintain many apoptotic cells characteristics such as
the presence of apoptotic microtubules, plasma membrane integrity,
low intracellular calcium levels, plasma membrane potential, PS
externalization and ability of being phagocytosed.
Stabilized apoptotic cells can be considered as dying cells in
which the cellular cortex and plasma membrane are maintained
intact or alive. In a metaphorical sense, we can consider them as
“living dead” or “zombie cells”.
Stabilization of apoptotic cells can be used for reliable detection
and quantiﬁcation of apoptosis in cultured cells and may allow a
safer administration of apoptotic cells in clinical applications.
Furthermore, it opens new avenues in the functional reconstruction
of apoptotic cells for longer preservation.
http://dx.doi.org/10.1016/j.redox.2015.09.020
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In this study, we assessed S-nitrosylation-based regulation of
Janus-activated kinase 2/signal transducer and activator of tran-
scription 3 (JAK2/STAT3) pathway. Our studies show that STAT3 in
stimulated microglia underwent two distinct redox-dependent
modiﬁcations, S-nitrosylation and S-glutathionylation. STAT3
S-nitrosylation was associated with inducible nitric oxide synthase
(iNOS)-produced nitric oxide (NO) and S-nitrosoglutathione
(GSNO), whereas S-glutathionylation of STAT3 was associated with
cellular oxidative stress. NO produced by iNOS or treatment of
microglia with exogenous GSNO inhibited STAT3 activation via
inhibiting STAT3 phosphorylation (Tyr705). Consequently, the
interleukin-6 (IL-6)-induced microglial proliferation and asso-
ciated gene expressions were also reduced. In cell-free kinase
assay using puriﬁed JAK2 and STAT3, STAT3 phosphorylation was
inhibited by its selective preincubation with GSNO, but not by
preincubation of JAK2 with GSNO, indicating that GSNO-mediated
mechanisms inhibit STAT3 phosphorylation through S-nitrosyla-
tion of STAT3 rather than JAK2. In this study, we identiﬁed that
Cys259 was the target Cys residue of GSNO-mediated S-nitrosyla-
tion of STAT3. The replacement of Cys259 residue with Ala
abolished the inhibitory role of GSNO in IL-6-induced STAT3
phosphorylation and transactivation, suggesting the role of
Cys259S-nitrosylation in STAT3phosphorylation.
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Since STAT3 activation is involved in tumor progression and
metastasis, we investigated the effect of GSNO in cell culture and
mouse xenograft model of head and neck squamous cell carci-
noma (HNSCC). GSNO treatment of HNSCCN cell lines reversibly
decreases the activation (phosphorylation) of STAT3 in a concen-
tration dependent manner. The reduced STAT3/NF-kB activity by
GSNO correlated with decreased cell proliferation and increased
apoptosis of HNSCC cells. In HNSCC mouse xenograft model, the
tumor growth was reduced by systemic treatment with GSNO and
was further reduced when the treatment combined with radiation
and cisplatin. Accordingly, GSNO treatment also resulted in
decreased levels of pSTAT3 and tumor growth regulators (ie. cyclin
D2, VEGF and Bcl-2) in tumor tissue. In summary, these ﬁndings
have implications for the development of new therapeutics
targeting of STAT3 for treating diseases associated with inﬂam-
matory/immune responses and abnormal cell proliferation, includ-
ing cancer.
http://dx.doi.org/10.1016/j.redox.2015.09.021
Mechanisms Of Hypoxia-Induced Immune Escape In
Cancer And Their Regulation By Nitric Oxide
Charles Graham, Ivraym Barsoum, Judy Kim, Madison Black, Robert
D. Siemens
Queen’s University, Kingston, Canada
The acquired ability of tumour cells to avoid destruction by
immune effector mechanisms (immune escape) is important for
malignant progression. Also associated with malignant progression is
tumour hypoxia, which induces aggressive phenotypes such as inva-
sion, metastasis and drug resistance in cancer cells. Our studies
revealed that hypoxia contributes to escape from innate immunity
by increasing tumour cell expression of the metalloproteinase
ADAM10 in a manner dependent on accumulation of the alpha
subunit of the transcription factor hypoxia-inducible factor-1 (HIF-
1α). Increased ADAM10 expression leads to shedding of the NK
cell-activating ligand, MICA, from the surface of tumour cells, thereby
resulting in resistance to NK cell-mediated lysis. Our more recent
studies demonstrated that hypoxia, also via HIF-1α accumulation,
increases the expression of the inhibitory co-stimulatory ligand PD-
L1 on tumour cells. Elevated PD-L1 expression leads to escape from
adaptive immunity via increased apoptosis of CD8+ cytotoxic T
lymphocytes. Accumulating evidence indicates that hypoxia-induced
acquisition of malignant phenotypes, including immune escape, is in
part due to impaired nitric oxide (NO)-mediated activation of cGMP
signalling and that restoration of cGMP signalling prevents such
hypoxic responses. We have shown that NO/cGMP signalling inhibits
hypoxia-induced malignant phenotypes likely in part by interfering
with HIF-1α accumulation via a mechanism involving calpain. These
ﬁndings indicate that activation of NO/cGMP signalling may have
useful applications in cancer therapy.
http://dx.doi.org/10.1016/j.redox.2015.09.022
Evaluating The Role Of Nitric Oxide Synthase In
Oncogenic Ras-Driven Tumorigenesis
Chris Counter
Duke University Medical Center, Durham, USA
We previously reported that oncogenic KRAS activation of the
PI3K/AKT pathway stimulates the remaining wild-type HRAS and
NRAS proteins in a manner dependent upon both eNOS expression
and C118 in HRAS and NRAS, which promoted tumor growth.
Interestingly however, we recently found that loss of wild-type HRAS,
NRAS, and even more potently, loss of both of these genes actually
enhanced oncogenic KRAS-driven early tumorigenesis. Taken together,
these results indicate that wild-type RAS proteins are tumor suppres-
sing early in tumorigenesis, but tumor promoting in more malignant
settings. Knock-in of a C118S mutation into an endogenous wild-type
RAS gene did not, however, hamper oncogenic KRAS-driven tumor
initiation. As such, redox-dependent reactions with C118 of wild-type
RAS proteins are unlikely to be responsible for the tumor suppressive
role of wild-type RAS proteins. This suggests that the redox-dependent
reactions with C118 of wild-type RAS proteins are more important in
more malignant settings. Given this, it stands to reason that inhibiting
redox-dependent reactions like S-nitrosylation of wild-type RAS
proteins may be more effective in established cancer settings. Indeed,
we ﬁnd that in three different models of KRAS-driven cancers-skin,
pancreatic and lung- the general NOS inhibitor L-NAME reduced tumor
burden and/or extended the lifespan of mice. Since oncogenic RAS has
so far proven refractory to pharmacologic inhibition, targeting NOS
activity may be an actionable approach to inhibiting RAS signaling for




Nitric Oxide And Hypoxia Response In Pluripotent
Stem Cells
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Díaz Contreras, Gladys M. Cahuana, Abdelkrim Hmadcha, Franz
Martín Bermudo, Bernat Soria, Juan R. Tejedo Huamán, Francisco J.
Bedoya Bergua
Andalusian Molecular Biology and Regenerative Medicine Centre
(CABIMER), Sevilla, Spain
The expansion of pluripotent cells (ESCs and iPSCs) under condi-
tions that maintain their pluripotency is necessary to implement a cell
therapy program. Previously, we have described that low nitric oxide
(NO) donor diethylenetriamine/nitric oxide adduct (DETA-NO) added
to the culture medium, promote the expansion of these cell types. The
molecular mechanisms are not yet known. We present evidences that
ESC and iPSCs in normoxia in presence of low NO triggers a similar
response to hypoxia, thus maintaining the pluripotency. We have
studied the stability of HIF-1α (Hypoxia Inducible Factor) in presence
of low NO. Because of the close relationship between hypoxia,
metabolism, mitochondrial function and pluripotency we have ana-
lyzed by q RT-PCR the expression of genes involved in the glucose
metabolism such as: HK2, LDHA and PDK1; besides other HIF-1α
target gene. We further analyzed the expression of genes involved in
mitochondrial biogenesis such as PGC1α, TFAM and NRF1 andwe have
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